Shafer Christina — SEC Form 4 filings
SEC reporting owner CIK 1934412. 6 Form 4 filings on record with FilingPulse; latest filed 2026-05-07.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-01-19 to 2026-05-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 5,973 shares, $24,937 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 2,153 shares @ $9.56 ($20,583) in MARINUS PHARMACEUTICALS, INC., filed 2024-02-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MARINUS PHARMACEUTICALS, INC. (MRNS) | CHIEF COMMERCIAL OFFICER | 5 | — | 2 legs · 5,973 sh · $24,937 | 12 |
| Neurogene Inc. (NGNE) | Chief Commercial Officer | 1 | — | — | 1 |
Form 4 filings — Shafer Christina
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-07 | 4 | Neurogene Inc. (NGNE) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Disposition to issuer (D): 18,778 @ $0.55 · Disposition to issuer (D): 48,628 @ $0.55 · Disposition to issuer (D): 49,125 (derivative) @ $0 · Disposition to issuer (D): 98,250 (derivative) @ $0 · Disposition to issuer (D): 78,188 (derivative) @ $0 · Disposition to issuer (D): 57,900 (derivative) @ $0 · +2 more | EDGAR |
| 2024-08-07 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Sale (S): 3,820 @ $1.14 | EDGAR |
| 2024-06-20 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Grant/award (A): 10,918 @ $0 · Grant/award (A): 49,125 (derivative) @ $0 | EDGAR |
| 2024-02-22 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Sale (S): 2,153 @ $9.56 | EDGAR |
| 2024-01-19 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Grant/award (A): 21,835 @ $0 · Grant/award (A): 98,250 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1934412 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →